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Introduction
Worldwide, heart failure (HF) is considered a major public 
health problem.1–9 Although there have been significant ther-
apeutic advances in pharmacological and surgical treatment 
of HF, hospital admission and readmission rates are 
extremely high for exacerbations of HF, and the 1-year mor-
tality rate of HF patients with progressive symptoms still 
approaches 40%.10–13 The high mortality and morbidity rates 
associated with HF are not completely explained by biologi-
cal mechanisms,14 as psychological factors are important 
predictors of morbidity and mortality in HF. One psycho-
logical factor that might contribute to morbidity and mortal-
ity in patients with HF is stress.14–20
Stress is the condition that occurs when environmental 
demands exceed an individual’s ability to adapt to the 
demands.21 A prerequisite for stress to occur is the individu-
al’s perception that stressors are perceived as a persistent 
threat to their physical and/or psychological health or 
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well-being.22 Stress is an umbrella term that summarizes the 
effects of psychological and environmental stressors on an 
individual’s physical and mental health.23,24 HF is commonly 
perceived by patients as a very stressful experience both 
physically and psychologically.16,25
There is limited information about the relationship 
between stress and HF. However, in patients with cardiovas-
cular disease, psychological stress was associated with mul-
tiple adverse effects on patient health outcomes.26–30 In 
patients with cardiovascular disease, psychological stress 
has been associated with decreased coronary artery blood 
supply, greater severity of cardiac disease, worse prognosis, 
and poorer cardiac function.31–35 Stress is also associated 
with multiple psychological factors such as anxiety and 
depression that have negative effects on health outcomes like 
mortality and morbidity in HF and cardiac disease.15,36–38
Given the likelihood that HF is a substantial stressor for 
many patients, the examination of the role of stress on health 
outcomes in patients with HF is important. The specific aims 
of this study were to (1) examine the association of stress 
with 6-month cardiac event-free survival, controlling for 
anxiety, depression, and New York Heart Association 
(NYHA) functional class; (2) examine the relationship of 
stress with salivary cortisol; and (3) examine the association 
of salivary cortisol level with 6-month cardiac event-free 
survival, controlling for age, gender, and NYHA class. We 
hypothesized that stress and salivary cortisol are predictors 
of event-free survival in HF patients. In addition, we hypoth-
esized that stress is a predictor of salivary cortisol level in 
HF patients.
Method
Design, sample, and setting
A prospective design was used in which patients were fol-
lowed for 6 months to determine occurrence of 6-month car-
diac event-free survival, defined as time to the combined 
endpoint of cardiac rehospitalization or all-cause death. 
This study was a part of the Heart Outcomes Prevention 
Evaluation (HOPE) study at the University of Kentucky that 
investigated depression among hospitalized patients with 
HF. The parent study and the current study were approved 
by the Institutional Review Board at the University of 
Kentucky. The sample consisted of 81 patients with con-
firmed HF who were hospitalized for cardiac reasons (i.e. 
hospitalization for HF, acute coronary syndrome, dysrhyth-
mias) at the University of Kentucky Chandler Medical 
Center or GoodSamaritanHospital, which are located in 
Lexington, Kentucky.
Patients with a diagnosis of chronic HF confirmed by 
echocardiogram and cardiologist were eligible for participa-
tion in the study if they met the following criteria: (1) admit-
ted to the hospital with a primary or secondary diagnosis of 
exacerbation of chronic HF or any other cardiac diagnosis, 
(2) 21 years or older, (3) able to read and speak English, and 
(4) no obvious cognitive impairment. Patients with HF with 
either preserved or non-preserved ejection fraction were 
included. Patients were excluded from the study for the fol-
lowing reasons: (1) co-existing terminal illness likely to be 
fatal within the next 6 months; (2) presence of a left ventricu-
lar assist device, continuous inotropic infusion, or hospice 
care; (3) active suicidality (defined as choosing option 2 or 3 
on item 9 of the Beck Depression Inventory-II); (4) history 
of the death of a spouse or child within the past month; (5) 
history of psychotic illness or bipolar illness; (6) current 
alcohol dependence or other substance abuse; and (7) new-
onset HF.
Measures
Stress
Stress was measured using the brief version of the Perceived 
Stress Scale.39 The brief version consists of a 4-item scale 
which has been demonstrated to be reliable and valid.39 The 
4 items are as follows: (1) How often have you felt that you 
were unable to control the important things in your life? (2) 
How often have you felt confident about your ability to han-
dle your personal problems? (3) How often have you felt that 
things were going your way? (4) How often have you felt 
difficulties were piling up so high that you could not over-
come them? Each item is rated by respondents on a scale 
ranging from 0 (never) to 5 (very often). Higher scores indi-
cate greater levels of stress. In this study, the Cronbach’s 
alpha of the 4-items perceived stress scale was 0.70.
Event-free survival
Event-free survival was defined as the combined endpoint of 
cardiac rehospitalization or all-cause death. Hospitalization data 
were determined through a combination of patient and family 
interviews and a review of medical records. Hospitalizations 
were verified by trained research assistants who reviewed medi-
cal records and clinic notes on a weekly basis. Given the possi-
bility that patients could have been hospitalized at different 
facilities other than the three sites involved in the study, trained 
research assistants carefully questioned the patients or family 
members by phone to determine whether hospitalization had 
occurred.
All-cause mortality was determined by interview with the 
patient’s family, medical record review, and review of county 
death records. At enrollment, the patient was asked for con-
tact information of a close friend or family member in case 
the patient could not be contacted. At follow-up, if a patient 
could not be reached by phone, hospital records were 
searched. When information regarding the patient was not 
available, family members or friends were contacted. If these 
contacts could not be reached, county death records were 
used to determine patient death.
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Salivary cortisol
Cortisol was measured from saliva obtained from patients at 
baseline through an unstimulated whole expectorated saliva 
collection protocol. Patients were provided a 20-mL vial con-
taining freeze dried protease inhibitor. Patients were asked to 
swallow once and begin expectorating approximately every 
20–30 s until 5 mL is collected. The specimen was kept on ice 
until returned to the lab. Salivary sample was obtained in the 
morning (9:00 a.m.) on the day of enrollment. The salivary 
samples were stored in a −80°C freezer until they were ana-
lyzed using a commercially available enzyme immunoassay 
kit designed for cortisol quantification in saliva (Salimetrics 
LLC, State College, PA, USA). This assay has a sensitivity of 
<0.007 µg/dL and is strongly correlated with serum cortisol 
measurement (0.91). Salivary cortisol is considered a more 
accurate and reliable measure for the clinical assessment of 
adrenocortical function than serum cortisol.40,41
Depressive symptoms
The Patient Health Questionnaire–9 (PHQ-9)42,43 was used 
to measure depressive symptoms. The PHQ-9 is a 9-item, 
self-reported measure of depressive symptom severity. 
Patients respond to each item on a Likert scale ranging from 
0 (not at all) to 3 (nearly every day). The total summary score 
can range from 0 to 27; a higher score reflects more severe 
depressive symptoms. Good internal consistency, stability, 
construct, and concurrent validity of the PHQ-9 have been 
supported.42,44 The standard published cut point of 10 was 
selected in this study for PHQ-9 to identify those in the sam-
ple who had moderate to severe depressive symptoms.28 This 
cut point was reported to have 88% sensitivity and 88% 
specificity for diagnosing major depression.44,45 In this study, 
the Cronbach’s alpha of the PHQ-9 scale was 0.73.
Anxiety
The Brief Symptom Inventory (BSI) anxiety subscale was 
used to measure anxiety.46,47 The subscale consists of six 
questions, each of which is scored by patients using a scale 
that ranges from 0 (not at all) to 4 (extremely). The total score 
is calculated as the mean of the 6-item scores. Thus, the pos-
sible range of scores for the anxiety scale is 0–4, with higher 
scores indicative of higher levels of anxiety. The BSI has 
demonstrated internal consistency, stability, construct, and 
concurrent validity in other studies.46,47 In this study, the 
Cronbach’s alpha of the anxiety scale was 0.77. A standard 
published mean score of 0.35 was used to identify those in the 
sample who were anxious and those who were not anxious.48
Demographic and clinical variables
Data on demographic variables and clinical characteristics 
were collected by reviewing medical records and interviewing 
patients. These variables included age, gender, ethnicity, and 
NYHA class. The NYHA class indicates the level of func-
tional impairment reported by patients as a result of symptoms 
and was rated by trained research nurses. These variables were 
selected because of their effects on the outcome variable as 
suggested in the literature.45,49
Procedure
Protocols for this study were approved by institutional 
review board of The University of Kentucky. All procedures 
were in accordance with institutional guidelines for research 
using human subjects. Hospitalized patients were identified 
by clinicians and referred to research staff. The research staff 
determined the patient’s eligibility. The study was thor-
oughly explained to each patient, and signed consent was 
obtained after answering any questions about the study. The 
research staff met with the patient to administer study ques-
tionnaires via the web-based SurveyMonkey. The question-
naires took approximately 20 min to complete. A paper copy 
also was offered to the patient if they did not feel comforta-
ble with the web-based survey.
As a part of HOPE study, patient were contacted by phone 
to complete the follow-up questionnaire at 2 weeks, 3 months, 
and 6 months from hospital discharge. At each telephone 
contact, the research staff asked the patient whether he or she 
has been hospitalized or visited the emergency unit. At the 
end of the study period and intermittently thereafter, hospital 
records were reviewed to confirm deaths, re-hospitalizations, 
or emergency department visits.
Salivary samples were obtained for cortisol measurement 
in the morning at baseline at the time of questionnaires com-
pletion. All saliva samples were stored at −80°C until analy-
sis of samples at the University of Kentucky Dentistry 
Research laboratory.
Statistical analysis
Data were analyzed using SPSS software, version 20.0 
(SPSS Inc., Chicago, IL, USA). Descriptive statistics, includ-
ing mean, standard deviation, and frequency distribution, 
were used to describe sample characteristics. To test Specific 
Aim 1, unadjusted, followed by adjusted, Cox regression 
analyses were used to determine whether stress indepen-
dently predicted event-free survival. The following covari-
ates were considered in the adjusted analysis and entered 
hierarchically: age, gender, NYHA class, and anxiety and 
depression. Demographic and clinical variables were entered 
first into the model. Then, anxiety and depressive symptoms 
were entered. Finally, stress as a continuous level variable 
was entered into the model. The same analysis was con-
ducted using categorical level variables with the mean and 
median as cut-points.
To test Specific Aim 2, linear and multiple regressions 
were used to determine the association of stress with salivary 
cortisol. This analysis included a sample of 70 patients 
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because not all of the patients were able to provide a salivary 
sample. Two groups, low and high salivary cortisol level, 
were created based on the median of salivary cortisol level 
and used in this analysis. This analysis was conducted using 
both categorical and continuous level variables of salivary 
cortisol. To test Specific Aim 3 using the same sample size 
(n = 70), unadjusted Cox regression analysis was conducted 
to determine whether cortisol predicted event-free survival. 
Then, a hierarchal Cox regression analysis was used control-
ling to the following covariates: age, gender, and NYHA 
class. Again, this analysis was conducted using both categor-
ical and continuous level variables of salivary cortisol. The 
demographic and clinical variables were entered first and 
cortisol was entered second. The assumptions of all Cox 
regressions, and linear and multiple regressions, were tested 
for violations and none were noted. A p-value of ≤0.05 was 
considered statistically significant.
Results
Demographic and clinical characteristics of patients (N = 81) 
are summarized in Table 1. The average stress score in this 
sample was 9.47 ± 3.86, with a range of 4–20. No cut point 
has been defined for this instrument to date; however, the 
mean stress score in this study was higher than has been 
reported in other studies for the same scale.39,50,51 For exam-
ple, in a study of college students, the mean score was 
5.6 ± 3.6,39 and in a study of Chinese patients with cardiac 
conditions, the mean was 6.0 ± 2.0.51
The average anxiety score was 0.58 ± 0.68. Using the 
published BSI average in the general population of 0.35,48 
46.7% scored as anxious. The average depressive symptoms 
score was 8.00 ± 4.87, and using the standard published 
PHQ-9 cut point 10,28 29.6% of the sample was suffering 
from depressive symptoms. The average salivary cortisol 
level was 0.32 ± 0.23 µg/dL.
Specific aim 1: stress and the prediction of event-
free survival
A total of 28 (35%) patients had an event. Six (7.4%) died 
and 22 (27.2%) were hospitalized for cardiac reasons during 
the study. In the unadjusted model, stress (heart rate 
(HR) = 1.04; 95% confidence interval (CI) = 0.95–1.13; 
p = 0.46) was not a predictor of event-free survival. In the 
adjusted model with age, gender, NYHA, anxiety, and 
depressive symptoms as covariates, the overall model 
(χ2 = 3.14, df = 6; p = 0.79) was not significant (Table 2). 
None of the variables were significant in any step of the 
hierarchal Cox regression. In the final model, stress 
(HR = 1.06; 95% CI = 0.95–1.81; p = 0.32) was not a predic-
tor of event-free survival. An additional exploratory Cox 
regression analysis was conducted using stress as a categor-
ical variable. The results were similar in that stress did not 
predict the outcome.
Specific aim 2: association of stress and salivary 
cortisol
The linear and multiple regressions (n = 70) showed that 
stress level was not a significant predictor of salivary cortisol 
(Tables 3 and 4). In addition, none of the covariate variables 
(age, gender, NYHA, and anxiety) in the multiple regression 
analysis was a significant predictor of salivary cortisol except 
age (HR = 0.26; 95% CI = 0.00–0.01; p = 0.04) (Table 4). An 
additional exploratory Cox regression analysis was con-
ducted using salivary cortisol as a categorical variable. The 
results were similar in that salivary cortisol did not predict the 
outcome.
Table 1. Sample characteristics (N = 81).
Characteristic N (%) or mean ± SD
Age, years 58.07 ± 13.07
Anxiety score 0.58 ± 0.63
Depressive symptoms score 8.00 ± 4.87
Stress score 9.47 ± 3.86
Cortisol level, µg/dL (N = 70) 0.32 ± 0.23
Gender
 Male 43 (53.1)
 Female 46 (46.9)
Ethnicity
 Caucasian 62 (76.5)
 African American 19 (23.5)
NYHA class
 I/II 39 (48.1)
 III/IV 42 (51.9)
Stress
 Not stressed 42 (51.9)
 Stressed 39 (48.1)
Anxiety
 Not anxious 44 (54.3)
 Anxious 37 (45.7)
Depression
 None/mild depression 57 (70.4)
 Moderate/severe 24 (29.6)
SD: standard deviation; NYHA: New York Heart Association.
Table 2. Adjusted Cox proportional hazards regression model 
of variables associated with cardiac event-free survival (stress 
model).
Predictor variables Hazard 
ratio
95% CI p
Age 1.01 0.98–1.04 0.57
Female gender 0.92 0.43–1.98 0.84
NYHA class III/IV compared to I/II 0.70 0.29–1.47 0.30
Anxiety 0.70 0.30–1.52 0.68
Depression 1.07 0.97–1.18 0.19
Stress 1.06 0.95–1.18 0.32
Final overall model (χ2 = 3.14, df = 6; p = 0.79)
CI: confidence interval; NYHA: New York Heart Association.
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Specific aim 3: salivary cortisol and the prediction 
of event-free survival
In the Cox regression analysis, where salivary cortisol level 
was the independent variable (n = 70), 24 patients (34.3%) 
had an event. In all, 4 (5.7%) of the participants died and 20 
(28.6%) were hospitalized during the study. In an unad-
justed model, salivary cortisol (HR = 2.30; 95% CI = 0.99–
5.93; p = 0.05) was a significant predictor of event-free 
survival (Table 5 and Figure 1). However, in the adjusted 
model with age, gender, and NYHA as covariates, the over-
all model (χ2 = 5.34, df = 4; p = 0.25) was not significant. 
None of the variables were significant in any step of the 
hierarchal Cox regression. In the final model, higher level of 
salivary cortisol (HR = 2.03; 95% CI = 0.84–4.93; p = 0.12) 
was not a predictor of event-free survival (Table 6). An 
additional exploratory Cox regression analysis was con-
ducted using salivary cortisol as a continuous variable. The 
results for both adjusted and unadjusted models were not 
significant.
Discussion
Psychosocial factors such as depression, anxiety, and lack of 
social support are associated with poor health outcomes in 
adults with HF.11,52 Clinicians and researchers commonly 
suggest that patients with HF have high levels of stress and 
that these levels of stress might contribute to poor out-
comes.53 To the best of our knowledge, this is the first study 
to investigate stress and associated cortisol level as predic-
tors of cardiac morbidity and all-cause mortality in patients 
with HF. Based on our literature review and the scientific 
background related to HF, stress, and morbidity and mortal-
ity, we hypothesized that stress and salivary cortisol would 
be a predictor of 6-month cardiac event-free survival. We 
also hypothesized a significant association between stress 
level and salivary cortisol level. None of these hypotheses 
were supported expect that salivary cortisol was a significant 
predictor of 6-month cardiac event-free survival in the unad-
justed model only. Our findings suggest that stress level was 
not associated with cardiac rehospitalization and mortality 
among HF patients.
Our hypotheses were based on the physiological mecha-
nisms whereby stress may affect the progression of cardio-
vascular disease in general. Stress is thought to involve the 
hypothalamic–pituitary–adrenocortical (HPA). Much of the 
research on animals and humans suggests that psychological 
factors can influence the HPA axis, which controls the release 
of cortisol, a glucocorticoid that is secreted by the adrenal 
cortex to support and control physiological functions.54 Over 
the past decades, many investigators have concluded that 
physical and psychological stressors are capable of activat-
ing the HPA axis and increasing cortisol level in the blood 
stream.54 Through cortisol, the HPA supports physiological 
functions and regulates other systems. However, prolonged 
elevation in cortisol due to frequent stress is associated with 
many negative biological effects such as suppression of the 
immune system, damage to hippocampal neurons, and devel-
opment and progression of chronic diseases like diabetes and 
hypertension.34,55 In HF, cortisol may contribute to the pro-
gression of cardiac damage by acting as a mineralocorticoid 
receptor (MR) agonist in the cardiac muscle where cortisol 
mimics the physiological and pathophysiological effects of 
aldosterone.56–59 Given these data, it is crucial to determine 
whether the stressors that are associated with HF activate the 
cortisol system and contribute to the onset or exacerbation of 
certain health outcomes.
Although there is evidence suggesting a relationship 
between stress and poor outcomes in cardiac patients without 
HF, the overall picture presented by the literature is one of 
conflicting findings.60 Stress, variably defined as psycho-
logical, psychosocial, and mental stress, has been shown to 
predict mortality and morbidity in patients with cardiovascu-
lar diseases.61–63 Others, with large sample sizes, have found 
no association between stress level and increased admission 
rates related to cardiovascular disease.64 In fact, some of 
Table 3. Linear regression of stress level associated with salivary 
cortisol of patients with heart failure.
Predictor 
variable
β 95% CI p
Stress −0.06 −0.02 to 0.01 0.60
Overall model (adjusted R2 = −0.01, F = 0.28; p = 0.60)
β: adjusted regression slope coefficient; CI: confidence interval.
Table 4. Multiple linear regression of variables associated with 
salivary cortisol of patients with heart failure.
Predictor variables β 95% CI p
Age 0.26 0.00 to 0.01 0.04
Female gender −0.20 −0.25 to 0.03 0.11
NYHA class III/IV 
compared to I/II
0.15 −0.07 to 0.23 0.27
Anxiety −0.002 −0.12 to 0.12 0.99
Stress −0.09 −0.03 to 0.01 0.55
Overall model (adjusted R2 = 0.056, F = 1.769; p = 0.133)
β: adjusted regression slope coefficient; CI: confidence interval; NYHA: 
New York Heart Association.
Table 5. Unadjusted Cox proportional hazards regression 
model of variables associated with cardiac event-free survival 
(salivary cortisol model).
Predictor variables Hazard 
ratio
95% CI p
High cortisol level 
compared to low level
2.30 0.99–5.927 0.05
Overall model (χ2 = 4.00, df = 1; p = 0.45)
CI: confidence interval.
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these investigators demonstrated an inverse relationship 
between stress and all-cause mortality, as well as cardiac 
mortality.64 Other investigators have demonstrated a differ-
ence between men and women in the prediction of mortality 
by stress in hospitalized medical patients.50,51 Stress in male 
patients predicted all-cause mortality; however, no associa-
tion was found between stress and mortality among 
women.65,66 Investigators explained those results by stating 
that men are more vulnerable to stress than women. In addi-
tion, they expressed concerns that use of the two-question 
short version of the perceived stress scale did not capture 
some aspects of the stress phenomena.65,66
Our neutral finding about the relationship between stress 
and outcomes may be related to our small sample size, yet 
other investigators with very large sample sizes have similarly 
failed to find an association.64 Although patients in our sample 
had a higher stress level compared to other populations,39,51 
the average score on the stress instrument was only moder-
ately high. Thus, it may be that patients in this sample did not 
experience a stress level high enough to demonstrate the 
hypothesized relationship. Another potential explanation for 
our finding is that the instrument did not adequately capture 
stress. We used the 4-item perceived stress scale, which has 
been demonstrated to be valid and reliable; nonetheless, the 
full instrument may have provided more complete informa-
tion about stress level than the short version.39,51,67 The 
6-month follow-up period may have been too short to capture 
the effect of stress on the health outcomes in patients with HF. 
Another possible explanation is that there is no relationship 
between stress level and outcomes in patients with HF. This 
explanation is supported by the number of investigations in 
which no relationship has been found in patients with a variety 
of health conditions.64,68,69 A final possible explanation is that 
there is an indirect association of stress with outcomes that is 
mediated through another construct such as coping.
We found no association between stress level and salivary 
cortisol level. Our findings are consistent with a study of 
breast cancer patients that showed no significant relationship 
between stress and salivary cortisol level.70 Our study was 
similar to this study of breast cancer patients in that medi-
cally ill individuals with conditions that may be stressful 
were studied. In a literature review71 designed to evaluate 
salivary cortisol as a biomarker of self-reported mental stress 
in field studies of healthy adults, the authors examined 14 
studies published in medium or high quality journals. Results 
from eight studies demonstrated no association between self-
reported mental stress and cortisol response: in four studies, 
there was a positive association, and in two studies a nega-
tive association.71 They concluded that in healthy adults, 
Figure 1. Event-free survival according to salivary cortisol level.
Table 6. Adjusted Cox proportional hazards regression model 
of variables associated with cardiac event-free survival (salivary 
cortisol model).
Predictor variables Hazard 
ratio
95% CI p
Age 1.01 0.97–1.04 0.69
Female gender 0.64 0.27–1.52 0.31
NYHA class III/IV 
compared to I/II
0.74 0.33–1.65 0.50
High cortisol level 
compared to low level
2.03 0.84–4.927 0.12
Overall model (χ2 = 5.34, df = 4; p = 0.25)
CI: confidence interval; NYHA: New York Heart Association.
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there were insufficient data to support a relationship and pos-
tulated that the association, if present, might only be evident 
in those with extremely high levels of stress. There are no 
other reviews more relevant to our sample of HF patients, 
but the suggestion that patients may need to experience very 
high levels of stress for the association to become evident is 
valid to our sample.
Our finding showed an association between salivary cor-
tisol level and all-cause mortality in patients with HF in the 
unadjusted model which is consistent with those of Yamaji 
et al.72 who found that serum cortisol levels were a predictor 
of cardiac events patients with chronic HF. However, in the 
adjusted model, that association was no longer significant. 
Similarly, others have found no such relationship between 
cortisol and acute coronary events among patients with acute 
coronary syndrome.73 The investigators relate their negative 
results to the interruption in cortisol rhythms during hospi-
talization, and this explanation may be relevant to our 
sample.
Study strengths and limitations
Strengths of our study include use of valid and reliable 
instruments to measure stress, salivary cortisol, and other 
covariates. Furthermore, we investigated multiple associa-
tions in this study that will form a foundation for future 
research in the field who are interested in stress and its effect 
on health outcomes in patients with HF.
The sample size of our study was a limitation that may 
have hindered our ability to demonstrate potential associa-
tions. As previously noted, however, a failure to find these 
associations has been noted in several studies with much 
larger sample sizes. The use of the 4-item perceived stress 
scale may limit the amount of information that we are able 
to collect related to stress; however, we used strict proto-
cols and reliable and valid instruments for patients with 
HF.47,74–76
Conclusion
Our findings suggest that there is no relationship between 
stress level, as measured using the 4-item Perceived Stress 
Scale, and cardiac rehospitalization and all-cause death in 
patients with HF. Our findings also suggest that in the setting 
of HF, a condition that produces high levels of background 
physiological stress, there is no association between self-
reported stress and salivary cortisol. Before these findings 
can be accepted, future studies among HF patients with 
higher levels of stress and in larger sample sizes must be 
conducted.
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